Search Results 31-40 of 14093 for Bilharzia

  1. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    This study is to evaluate the safety, efficacy and clinical benefit of BGB-3111 vs ibrutinib in subjects with MYD88 Mutation Waldenström's Macroglobulinemia.

  2. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  3. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  4. Home Care Treatment With Oral Chemotherapy For Recurrent Or Metastatic Oral Cavity Cancer - Mayo Clinic

    About this study. The purpose of this study is to demonstrate feasibility of conducting a decentralized therapeutic clinical trial of triple oral metronomic ...

  5. A Study to Evaluate Molecular and Biochemical Testing for Suspected Hereditary Disorders - Mayo Clinic

    About this study. The objectives of this study are to perform molecular and/or biochemical testing in individuals with suspected hereditary disorders, ...

  6. Naiara Sbroggio Barbosa, M.D. - Doctors and Medical Staff - Mayo Clinic

    Barbosa is board-certified in Dermatology and Mohs surgery by the American Board of Dermatology. Dr. Barbosa received her medical degree from the University of ...

  7. Jamilah Shubeilat, M.B.B.S., M.D. - Doctors and Medical Staff - Mayo Clinic

    Shubeilat is an Infectious Disease Physician, board certified in Infectious Diseases as well as Internal Medicine. Dr. Shubeilat holds a master in public health ...

  9. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

  10. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

    About this study. The purpose of this study is to determine if the invasive disease-free survival (iDFS) with T-DM1 and tucatinib is superior to the iDFS in ...